Skip to main content

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Agency: National Institutes of Health

Assistance Listings
  • 93.394 -- Cancer Detection and Diagnosis Research
  • 93.395 -- Cancer Treatment Research

Open opportunityLast Updated: Sep 30, 2026

Important dates

  • Closing: January 11, 2027

Award details

  • Expected project funding: $4,400,000
  • Expected awards: 4

Award min.

Not specified

Award max.

$700,000

  • Funding opportunity number:RFA-CA-27-005
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Posted date: August 31, 2026
  • Archive date: March 11, 2027
  • Version: 2

View version history on Grants.gov

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.

To implement this concept, a highly collaborative GBM Therapeutics Network (GTN) of cross-cutting teams will be established, each team capable of driving therapeutic agent(s) from pre-clinical development, through investigational new drugs (IND) studies, into pilot clinical studies in humans. Appropriate therapeutic agents include: (1) novel agents or (2) agents or combinations approved for other indications and repurposed for treatment of GBM following appropriate preclinical studies. The scope of the NOFO, from late pre-clinical through early (Phase 0/1) clinical studies, uniquely spans a gap in the GBM drug development process.

Eligibility

Business

  • Small businesses
  • For-profit organizations other than small businesses

Government

  • City or township governments
  • State governments
  • Special district governments
  • County governments
  • Federally recognized Native American tribal governments
  • Public and Indian housing authorities

Education

  • Private institutions of higher education
  • Public and state institutions of higher education
  • Independent school districts

Nonprofit

  • Other Native American tribal organizations
  • Nonprofits non-higher education without 501(c)(3)
  • Nonprofits non-higher education with 501(c)(3)

Miscellaneous

  • Other

Additional information on eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Documents

File nameDescriptionLast updated
RFA-CA-27-005-Revised-Full-Announcement.html
RFA-CA-27-005-Revised-Full-Announcement.html
Sep 30, 2026 07:56 PM UTC

Agency contact information

Email: GTN-contacts@nih.gov

National Cancer Institute (NCI)

NCI GTN Program National Cancer Institute (NCI) GTN-contacts@nih.gov

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov